Church & Dwight ruling upheld
This article was originally published in The Tan Sheet
Executive Summary
U.S. Court of Appeals for Federal Circuit denies the appeal of Evident Corporation and Peroxydent Group on Feb. 22 in the patent infringement lawsuit filed against Colgate and Church & Dwight in June 1997. The previous ruling stated Evident's U.S. Patent No. 4,971,782 involving the production of baking soda and peroxide toothpaste was unenforceable. The New Jersey District Court ruled against Peroxydent, contending that Evident had sufficient standing to bring the original lawsuit against C&D and Colgate. The Court also affirmed its original judgment that the case was exceptional and the resulting legal payouts from Evident and Peroxydent to C&D were reasonable...
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.